Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Drug Manufacturers - Other Sector (CIX: MSECTOR511)
2,241.57   +6.36 (+0.28%)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Sector News
Stories about Drug Manufacturers - Other Sector
 
< Previous 1 2 3 Next >
Will Phillip Frost bid for TLO in bankruptcy?
Today 17:02 EDT
Wealthy entrepreneur Phillip Frost has joined a new acquisition company making an appearance in the Chapter 11 bankruptcy procedure of Boca Raton data company TLO LLC... Read More
category Thomson Reuters , Phillip Frost , Legal Services , and 13 more.
from Business Journals
Commit To Purchase Orexigen Therapeutics At $3, Earn 23.3%
Today 14:18 EDT
Investors eyeing a purchase of Orexigen Therapeutics, Inc. (OREX) stock, but cautious about paying the going market price of $6.33/share, might benefit from considering selling puts among the... Read More
category Stocks
from Market News Video
Commit To Purchase Orexigen Therapeutics At $3, Earn 23.3%
Today 14:18 EDT
Investors eyeing a purchase of Orexigen Therapeutics, Inc. (OREX) stock, but cautious about paying the going market price of $6.33/share, might benefit from considering selling puts among the... Read More
category Dividends
from Dividend Channel
Amarin Stays Rangebound, Prescriptions Stagnate
Today 14:05 EDT
Amarin Corporation (NASDAQ: AMRN) has been struggling a lot lately as retail channel prescription data for its EPA capsule Vascepa imply that the drug is starting to slow down its momentum in the... Read More
category AMRN , Bio/Wire
from Bio-Wire.Com
Notable Two Hundred Day Moving Average Cross - ALXN
Today 12:34 EDT
In trading on Thursday, shares of Alexion Pharmaceuticals Inc. (ALXN) crossed below their 200 day moving average of $98.73, changing hands as low as $98.00 per share. Read More
category Stocks
from Market News Video
EmergingGrowth.com Looks at New Payment Platform, Record Numbers Company
Today 11:46 EDT
from ACCESSWIRE
REFILE-UPDATE 1-Forest Labs' longtime CEO Solomon to step down at year-end
Today 11:39 EDT
May 23 (Reuters) - Forest Laboratories Inc said Howard Solomon, its chief executive of more than 35 years, will retire at the end of this year, capping a tenure that saw the company morph from a small... Read More
category companyNews
from Reuters: Company News
Cubist Pharmaceuticals Up 25.2% Since SmarTrend Uptrend Call (CBST)
Today 10:42 EDT
from Comtex SmarTrend® News Briefs
29.3% Return Seen to Date on SmarTrend Amarin Call (AMRN)
Today 10:19 EDT
from Comtex SmarTrend® News Briefs
Zensun Announces Positive Data from Phase II Trials of Neucardin
Today 10:14 EDT
Zensun Sci & Tech, Ltd., a Shanghai-San Diego biopharma, reported positive results from four Phase II trials of its lead drug candidate, Neucardin™, a treatment for heart failure. Because of the... Read More
from ChinaBio® Today
Oakmark Fund Buys Forest Laboratories, DirecTV, UnitedHealth, Apple
Today 9:43 EDT
Oakmark Fund Buys Forest Laboratories, DirecTV, UnitedHealth, Apple Read More
category NYSE:BAC , NASD:AAPL , NYSE:FRX , and 2 more.
from Forbes Real Time
Forest Labs (FRX) CEO to Retire at End of Year
Today 8:05 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8364557 for the full story. Read More
from StreetInsider.com News Articles
Needham & Company Starts Lannett Co (LCI) at Buy
Today 7:49 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8364390 for the full story. Read More
from StreetInsider.com News Articles
Will Ranbaxy Labs Be Excluded From Medicare And Medicaid?
May 22, 2013
One week after Ranbaxy Laboratories agreed to pay $500 million to resolve civil and criminal charges stemming from a long-running manufacturing scandal that involved substandard products and providing... Read More
category RBXY:NATLINDIA , NYSE:FRX
from Forbes Real Time
United Therapeutics Has Returned 35.1% Since SmarTrend Recommendation (UTHR)
May 22, 2013
from Comtex SmarTrend® News Briefs
Amarin Corporation (AMRN) gains on patent news
May 22, 2013
Amarin Corporation plc (NASDAQ: AMRN) added 1.9% to $7.11 after the company announced patent allowance related to combination product of Vascepa and Statin therapy. Share volume was 126,000, compared... Read More
from BAYSTREET RSS FEED
8 Biotechnology Stocks to Sell Now
May 22, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 6 more.
from InvestorPlace - Latest Headlines
Amarin Receive Patent Allowance for Combination Product of Vascepa and Statin Therapy
May 22, 2013
Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the United... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Bio-Wire Equity Surveillance – Closing Bell 5/21/2013
May 21, 2013
Larger pharmaceutical companies generally kept their net gains in a modest range, with companies between $10-200B in market cap seeing gains within the range of +.5-1% while medium sized companies in... Read More
category TLON , PPHM , SCMP , and 5 more.
from Bio-Wire.Com
Breaking up physicians and pharma ties could improve care, report says
May 21, 2013
Although the relationship between pharmaceutical companies and doctors is widely accepted, researchers from Oregon State University, Oregon Health & Science University and the University of Washington... Read More
category Allergan Inc/ , Oregon State University , University of Washington , and 6 more.
from Business Journals
Investors Begin To Realize RNA’s Potential
May 21, 2013
from ACCESSWIRE
Charting a persistent May uptrend
May 21, 2013
The major U.S. stock benchmarks have knifed to less-charted territory, and the technical price action is holding true to form. Read More
category Retail , Opinion , MYGN , and 16 more.
from MarketWatch
Pre-Market Analysis on STSI, IPXL, PCYC, and UTHR
May 21, 2013
from ACCESSWIRE
Today’s Research on CELG, ARNA, INCY, SPPI, and GERN
May 21, 2013
from ACCESSWIRE
Notable Analyst Rating Changes 05/21: (CNQ) (CBST) (WTSL) Upgraded; (CCL) (DB) (COH) Downgraded
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8358093 for the full story. Read More
from StreetInsider.com News Articles
70.4% Return Seen to Date on SmarTrend Sucampo Pharmaceuticals Call (SCMP)
May 21, 2013
from Comtex SmarTrend® News Briefs
Upgrade Alert for Cubist Pharmaceuticals (CBST)
May 21, 2013
from Comtex SmarTrend® News Briefs
Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8356836 for the full story. Read More
from StreetInsider.com News Articles
U.S. court ruling favors Cubist in patent case versus Hospira
May 20, 2013
A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc . Read More
from FOX News
U.S. court ruling favors Cubist in patent case vs Hospira
May 20, 2013
May 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin... Read More
category companyNews
from Reuters: Company News
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here